Automated Postoperative Sedation After Cardiac Surgery

NCT ID: NCT03517735

Last Updated: 2021-11-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-12-17

Study Completion Date

2019-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares automated administration of propofol and remifentanil guided by the Bispectral index (BIS) versus manual administration for sedation after cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Automated sedation has the potential to improve patient care after cardiac surgery by adjusting drug doses to the minimum required for efficacy. Indeed, automated and continuous titration may avoid overdosing, improve hemodynamic stability and also decrease the mean time to tracheal extubation.

Medsteer SAS developed a controller, EasyTiva device, allowing the closed-loop coadministration of propofol and remifentanil, guided by a Bispectral Index (BIS) monitor.

Automated sedation is so facilitated by the BIS which permits continuous monitoring of electrocortical activity.

This randomized monocentric trial compares the automated administration with manual intravenous administration of propofol-remifentanil for maintaining adequate depth of hypnosis (BIS 55-75) during sedation after cardiac surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia Sedation Surgery, Cardiac

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Automated postoperative sedation

Automated administration of Propofol and Remifentanil.

Group Type EXPERIMENTAL

EasyTiva (algorithm is the property of Medsteer SAS)

Intervention Type DEVICE

Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.

Propofol

Intervention Type DRUG

The dosage is modified automatically by the device or according to the new medical prescription.

Remifentanil

Intervention Type DRUG

The dosage is modified automatically by the device or according to the new medical prescription.

Manual postoperative sedation

Manual administration of Propofol and Remifentanil.

Group Type ACTIVE_COMPARATOR

Propofol

Intervention Type DRUG

The dosage is modified automatically by the device or according to the new medical prescription.

Remifentanil

Intervention Type DRUG

The dosage is modified automatically by the device or according to the new medical prescription.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EasyTiva (algorithm is the property of Medsteer SAS)

Propofol and Remifentanil are administered automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 55 and 75.

Intervention Type DEVICE

Propofol

The dosage is modified automatically by the device or according to the new medical prescription.

Intervention Type DRUG

Remifentanil

The dosage is modified automatically by the device or according to the new medical prescription.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cardiac surgical procedure requiring postoperative sedation
* Low operative risk : EuroSCORE 2 ≤ 5%
* Consent for participation
* Affiliation to the social security system

Exclusion Criteria

* Pregnant or breastfeeding women
* Neurological or muscular disorder
* Pacemaker
* Hypersensitivity to propofol or remifentanil
* Communication difficulties or neuropsychiatric disorder
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CMC Ambroise Paré

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thierry Chazot, MD

Role: STUDY_CHAIR

Hôpital FOCH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CMC Ambroise Paré

Neuilly-sur-Seine, Île-de-France Region, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Liu N, Chazot T, Hamada S, Landais A, Boichut N, Dussaussoy C, Trillat B, Beydon L, Samain E, Sessler DI, Fischler M. Closed-loop coadministration of propofol and remifentanil guided by bispectral index: a randomized multicenter study. Anesth Analg. 2011 Mar;112(3):546-57. doi: 10.1213/ANE.0b013e318205680b. Epub 2011 Jan 13.

Reference Type RESULT
PMID: 21233500 (View on PubMed)

Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013 Mar;39(3):454-62. doi: 10.1007/s00134-012-2762-2. Epub 2012 Dec 6.

Reference Type RESULT
PMID: 23223772 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017/03

Identifier Type: -

Identifier Source: org_study_id